Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
How Does the Market Size of the Gut Microbiota Market in 2029 Compare With That of 2025?
The gut microbiota market size has grown rapidly in recent years. It will grow from $0.55 billion in 2024 to $0.65 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to the discovery of probiotics and prebiotics, the rise in gastrointestinal disorders, the growing interest in functional foods, the increasing use of antibiotics, and the rise in awareness of the gut-brain axis.
The gut microbiota market size is expected to see rapid growth in the next few years. It will grow to " $1.25 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to expanding personalized nutrition, rising demand for microbiome-based therapeutics, growth in functional and fermented foods, and regulatory support for probiotics and prebiotics. Major trends in the forecast period include artificial intelligence (AI)-driven microbiome analysis, next-generation sequencing advancements, CRISPR-based gut microbiota editing, development of smart probiotic delivery systems, and wearable gut health monitoring devices.
Get your free report sample today:
Which Key Dynamics Are Contributing to the Expansion of the Gut Microbiota Market?
The growing demand for personalized medicine is expected to propel the growth of the gut microbiota market going forward. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is growing as advancements in genomics and biotechnology enable more precise identification of genetic profiles, allowing for tailored treatments that improve effectiveness and reduce side effects. Personalized medicine is useful for gut microbiota by tailoring treatments based on an individual's unique microbiome composition, optimizing gut health, and improving outcomes for digestive and metabolic disorders. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant rise compared to the 12 approved in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the gut microbiota market.
Which Key Segments Are Included in the Gut Microbiota Market Analysis?
The gut microbiotamarket covered in this report is segmented –
1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products
2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health
3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores
4) By End-Users: Adults; Children; Elderly
Subsegments:
1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins
2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia
3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives
4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts
5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products
What Are the Most Prominent Trends Impacting the Gut Microbiota Market?
Major companies operating in the gut microbiota market are focusing on developing innovative solutions, such as orally administered fecal microbiota, to address various gastrointestinal diseases and disorders. Orally administered fecal microbiota refers to a treatment in which a capsule or pill containing beneficial bacteria from a healthy donor's stool is taken to restore balance to the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, received FDA approval for Vowst, the first oral fecal microbiota product designed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use after antibacterial treatment for recurrent CDI. This approval marks a significant advancement in CDI treatment, providing a more accessible and patient-friendly alternative to traditional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral formulation may improve treatment adherence and expand the adoption of microbiome-based therapies in healthcare.
Who Are the Key Strategic Players in the Gut Microbiota Market Ecosystem?
Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.
Get the detailed gut microbiota market report today
What Are the Fastest-Growing Regions in the Gut Microbiota Market?
North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment